Breakthrough in cancer treatment: Allows cancer cells to be reversed to normal
Scientists have just announced a breakthrough invention in the field of cancer treatment, allowing cancer cells to be reversed to a normal state without destroying them.
This is not only a major step forward in cancer treatment , but also offers hope for patients to avoid the side effects of traditional treatments and the risk of drug resistance.
According to a report on IFLScience on December 26, 2024, this research opens up a new treatment direction that can change the approach to cancer by restoring the normal function of cancer cells.
Instead of destroying them like current treatments, this technique helps cancer cells return to a state of differentiation, meaning they return to the morphology of benign cells, no longer malignant.
The concept of reversing cancer, of turning cancer cells back to a normal state, is not new in biomedical research. Cancer cells are often undifferentiated, meaning they do not develop into specialized cells like normal cells. Reactivating the differentiation process in cancer cells could be a potential treatment in the future.
Cell differentiation is the process by which a cell changes from a primitive form to a more specialized cell type. This process can help cells perform specific functions and adapt to their environment.
By regenerating genes involved in the differentiation process, scientists can "reactivate" cancer cells and restore their normal function.
This process can even lead to a more advanced form of differentiation, called “transdifferentiation,” where cancer cells are converted into an entirely different type of cell. For example, breast cancer cells can be transformed into liver cells, with more specialized functions.
Previous studies have shown that it is possible to reverse some types of cancer cells, such as breast cancer, myeloid leukemia, and hepatocellular carcinoma. However, scientists have not yet clearly identified the specific genes or proteins that control this differentiation process, which remains a major challenge in developing effective cancer therapies.
In the latest study, a research team led by Professor Kwang Hyun Cho, from the Department of Bioengineering and Brain Engineering at the Korea Advanced Institute of Science and Technology (KAIST), has developed a new technology that can convert colon cancer cells into normal cells.
The technology is based on building digital replicas of the gene networks involved in normal cell differentiation. Thanks to this simulation, the team was able to identify key factors needed to reactivate the cell differentiation process.
Using this technology, scientists have successfully transformed colon cancer cells back into normal cells. This study demonstrates that reversing the cancerous state of cells is entirely possible, and that through analyzing digital copies of gene networks, cancer cells can be reprogrammed to become benign cells.
Speaking about the research, Professor Kwang Hyun Cho said: "It is a wonderful phenomenon that cancer cells can be reversed into normal cells. This study proves that we can induce such reversal systematically and can be applied to many different types of cancer cells."
The research has been published in the journal Advanced Science and is expected to usher in a new era in the development of cancer therapies, bringing hope to millions of patients around the world.